For the Inventor, By the Inventor

Enter assignee name

Vienna, VA, United States of America

Cel-sci Corporation

USPTO Granted Patents = 16

EPO Patents = 6

Trademarks = 1

Forward Citations = 69

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Daniel H Zimmerman (14 out of 18 patents)

Eyal Talor (4 out of 4 patents)

Prem S Sarin (4 out of 6 patents)

4. Kenneth Rosenthal (2 out of 2 patents)

5. Donald A Elliott (2 out of 3 patents)

6. Kanta Subbarao (1 out of 6 patents)

7. Kobporn Boonnak (1 out of 1 patent)

8. Katalin Mikecz (1 patent)

9. Harold Steiner (0 patent)

10. Roy Carambula (0 patent)

11. Tibor Glant (0 patent)

12. Geert Kersten (0 patent)

16 patents: Sort by Forward Citations

1. 11041013 - Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis (2021-06-22),

2. 10238747 - Method for inducing an immune response against avian, swine, spanish, H1N1, H5N9 influenza viruses and formulations thereof (2019-03-26),

3. 10179174 - Method for inducing an immune response and formulations thereof (2019-01-15),

4. 10179164 - Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions (2019-01-15),

5. 7256254 - Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions (2007-08-14),

6. 7199216 - Peptide constructs for treating autoimmune and related diseases (2007-04-03),

7. 6995237 - Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions (2006-02-07),

8. 6951647 - T cell binding ligand peptides and method of inducing a cellular immune response (2005-10-04),

9. 6896879 - Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture (2005-05-24),

10. 6572860 - Immunogenic conjugated polypeptide for treatment of herpes simplex virus (2003-06-03),

11. 6287565 - Modified HGP-30 heteroconjugates, compositions and methods of use (2001-09-11),

12. 6268472 - Modified HGP-30 peptides, conjugates, compositions and methods of use (2001-07-31),

13. 6103239 - Modified HGP-30 heteroconjugates, compositions and methods of use (2000-08-15),

14. 6096315 - Heterofunctional cellular immunological reagents, vaccines containing (2000-08-01),

15. 6093400 - Modified HGP-30 peptides, conjugates, compositions and methods of use (2000-07-25),

CEL-SCI Corporation is a biotechnology company that is focused on the development of immunotherapy products for the treatment of cancer and other diseases. The company's lead product is Multikine, a drug that is being developed for the treatment of head and neck cancer. CEL-SCI is also working on other immunotherapy products for various diseases. The company's mission is to improve the treatment and outcomes for patients with cancer and other diseases through the development of innovative immunotherapy products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

16 Patents

#7 in Vienna, VA

#338 in Virginia

#19,269 in US

#36,651 in the World

Vienna, VA, United States of America

Cel-sci Corporation

Forward Citations = 69

7 inventors:

Daniel H Zimmerman (14 out of 18 patents)

Eyal Talor (4 out of 4 patents)

Prem S Sarin (4 out of 6 patents)

4. Kenneth Rosenthal (2 out of 2 patents)

5. Donald A Elliott (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…